Real-time Estimate
Cboe Europe
15:55:00 01/05/2024 BST
|
5-day change
|
1st Jan Change
|
292.7
DKK
|
-2.11%
|
|
+1.37%
|
-23.92%
|
Fiscal Period: Juni |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14,679
|
13,174
|
8,110
|
5,203
|
-
|
-
|
Enterprise Value (EV)
1 |
14,679
|
13,174
|
7,800
|
4,860
|
4,800
|
4,741
|
P/E ratio
|
166
x
|
82.6
x
|
45.4
x
|
38.9
x
|
33.2
x
|
27.5
x
|
Yield
|
-
|
0.53%
|
-
|
2.17%
|
2.68%
|
2.84%
|
Capitalization / Revenue
|
-
|
30.8
x
|
18.3
x
|
12.9
x
|
11.1
x
|
9.54
x
|
EV / Revenue
|
-
|
30.8
x
|
17.6
x
|
12
x
|
10.2
x
|
8.69
x
|
EV / EBITDA
|
-
|
59.1
x
|
31.1
x
|
26.3
x
|
21.5
x
|
17.8
x
|
EV / FCF
|
-
|
-
|
68.8
x
|
46.7
x
|
35
x
|
30.9
x
|
FCF Yield
|
-
|
-
|
1.45%
|
2.14%
|
2.86%
|
3.23%
|
Price to Book
|
-
|
-
|
15.2
x
|
8.71
x
|
7.67
x
|
8.48
x
|
Nbr of stocks (in thousands)
|
17,402
|
17,402
|
17,402
|
17,402
|
-
|
-
|
Reference price
2 |
843.5
|
757.0
|
466.0
|
299.0
|
299.0
|
299.0
|
Announcement Date
|
17/09/21
|
15/09/22
|
13/09/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
427.2
|
442.3
|
403.5
|
470.7
|
545.3
|
EBITDA
1 |
-
|
222.9
|
251
|
185
|
223
|
266.7
|
EBIT
1 |
-
|
202.9
|
230.6
|
176.3
|
201
|
242
|
Operating Margin
|
-
|
47.48%
|
52.13%
|
43.7%
|
42.71%
|
44.38%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
230.4
|
177
|
201
|
242
|
Net income
1 |
88.35
|
159.5
|
178.7
|
133.8
|
156.9
|
189
|
Net margin
|
-
|
37.34%
|
40.4%
|
33.15%
|
33.34%
|
34.66%
|
EPS
2 |
5.080
|
9.160
|
10.27
|
7.694
|
9.016
|
10.87
|
Free Cash Flow
1 |
-
|
-
|
113.3
|
104
|
137.3
|
153.3
|
FCF margin
|
-
|
-
|
25.62%
|
25.77%
|
29.18%
|
28.12%
|
FCF Conversion (EBITDA)
|
-
|
-
|
45.15%
|
56.22%
|
61.58%
|
57.5%
|
FCF Conversion (Net income)
|
-
|
-
|
63.43%
|
77.75%
|
87.52%
|
81.12%
|
Dividend per Share
2 |
-
|
4.000
|
-
|
6.500
|
8.000
|
8.500
|
Announcement Date
|
17/09/21
|
15/09/22
|
13/09/23
|
-
|
-
|
-
|
Fiscal Period: June |
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
108.1
|
199.3
|
98.9
|
106
|
203
|
216
|
224
|
EBITDA
1 |
51.6
|
93.1
|
43.5
|
49.7
|
91
|
101
|
96
|
EBIT
1 |
-
|
84.65
|
43.5
|
49.7
|
82
|
92
|
86
|
Operating Margin
|
-
|
42.47%
|
43.98%
|
46.86%
|
40.39%
|
42.59%
|
38.39%
|
Earnings before Tax (EBT)
|
-
|
89.02
|
-
|
-
|
83
|
93
|
88
|
Net income
1 |
-
|
70.56
|
43.5
|
49.7
|
65
|
72
|
68
|
Net margin
|
-
|
35.4%
|
43.98%
|
46.86%
|
32.02%
|
33.33%
|
30.36%
|
EPS
2 |
-
|
4.050
|
2.500
|
2.850
|
3.720
|
4.160
|
3.920
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/02/24
|
05/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: June |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
309
|
343
|
403
|
463
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
113
|
104
|
137
|
153
|
ROE (net income / shareholders' equity)
|
-
|
51.4%
|
39.5%
|
23.6%
|
24.6%
|
26.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
20.5%
|
20.5%
|
21.8%
|
Assets
1 |
-
|
-
|
-
|
652.1
|
764.9
|
866.7
|
Book Value Per Share
2 |
-
|
-
|
30.60
|
34.30
|
39.00
|
35.30
|
Cash Flow per Share
2 |
-
|
10.20
|
8.860
|
8.000
|
10.00
|
11.90
|
Capex
1 |
-
|
-
|
40.8
|
47.6
|
43.1
|
53.4
|
Capex / Sales
|
-
|
-
|
9.23%
|
11.79%
|
9.16%
|
9.79%
|
Announcement Date
|
17/09/21
|
15/09/22
|
13/09/23
|
-
|
-
|
-
|
Average target price
462.5
DKK Spread / Average Target +54.68% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.92% | 746M | | +73.20% | 12.38B | | -19.55% | 7.61B | | +13.60% | 7.11B | | +4.77% | 5.83B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -19.09% | 4.02B | | -31.51% | 2.16B | | +1.24% | 2.01B |
Medical Equipment
|